Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-006553
Filing Date
2025-03-04
Accepted
2025-03-04 16:31:26
Documents
1
Period of Report
2025-03-03

Document Format Files

Seq Description Document Type Size
1 form4-03042025_090322.html 4  
1 form4-03042025_090322.xml 4 9324
  Complete submission text file 0001415889-25-006553.txt   10863
Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Issuer) CIK: 0001620463 (see all company filings)

EIN.: 453368487 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ATHIRA PHARMA, INC. 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address
Renninger Robert (Reporting) CIK: 0002037968 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39503 | Film No.: 25705195